chrisvoncsefalvay/vaers-outcomes huggingface dataset:
It didn't give patient the flu or even flu like symptoms, but patient I felt crappy for about 4 days after; Initial information was received on 05-Dec-2020 regarding an unsolicited non-valid non-serious case from a non-health care professional/consumer (patient) via social media.  This case involves a patient of unknown age for whom it was reported that it didn't gave patient the flu or even flu like symptoms, but patient felt crappy for about 4 days after (feeling abnormal), while patient was treated with influenza vaccine.  Medical history, medical treatment(s) and family history were not provided.  Concomitant medication was not reported.  On an unknown date, the patient received influenza vaccine [lot number: unknown and expiration date: unknown] at an unknown dose via an unknown route in an unknown administration site for prophylactic vaccination.  On an unknown date, (latency: unknown) after starting the suspect vaccine therapy, patient reported it was reported that it didn't gave patient the flu or even flu like symptoms, but patient felt crappy for about 4 days after (feeling abnormal).  It was not reported if the patient received any corrective treatment.  At the time of reporting, outcome of the events was unknown.  There will be no information available regarding batch number in this case.
Employee reports dizziness, headaches and nausea two days after second dose vaccine. This then went away for a month. Reports that she began again to have dizziness, nausea and headaches, "feels her eyes are constantly moving" March 15 Saw an urgent care provider and went to emergency Room on 3/22 for dizziness.
Possibly ?COVID arm?. Large red patch around injection site  which showed up 12 days after injection. No pain but some itching. Slightly warm to the touch. The patch has increased in size since first being noticed ( 1 1/2 days ago)  Looks very much like those seen on websites describing COVID arm.  No other symptoms.  There were no reactions at time of injection.
a ball on the arm; Headache; Body ache; Chills; Redness on the arm; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (a ball on the arm), HEADACHE (Headache), MYALGIA (Body ache), CHILLS (Chills) and ERYTHEMA (Redness on the arm) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 006M20A and 029L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.   On 01-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PERIPHERAL SWELLING (a ball on the arm), HEADACHE (Headache), MYALGIA (Body ache), CHILLS (Chills) and ERYTHEMA (Redness on the arm). At the time of the report, PERIPHERAL SWELLING (a ball on the arm), HEADACHE (Headache), MYALGIA (Body ache), CHILLS (Chills) and ERYTHEMA (Redness on the arm) outcome was unknown.            no concomitant medications reported. no treatment details reported.
Pt had severe projectile vomiting 48 hours after recieving vaccine, had bloody stools 72 hours after recieving vaccination and was diagnosed with Intussusception of the intestines 78 hours after receiving vaccination. 2/25/08-records received for DOS 2/18-2/19/08-DC DX: Intussusception. Presented to ED with projectile vomiting and inability to take PO and 2 episodes of bloody stools fever of 101.0 (R).
Within 20 mins of vaccination, a hive formed at site of injection with red border 2 1/2 in x 2 1/2 in (lasted 24-30), no wheezing, body/face swelling, no resp distress.
This spontaneous report as received from a physician via a company representative, refers to a patient of unknown age and gender. The patient's concurrent conditions and medical history were not provided. On 22-FEB-2016, the patient was vaccinated with an improperly stored dose of RECOMBIVAX HB "10Pk 10mcg/1mL SD LLok Cap AD", lot # L001441 with expiration date 17-AUG-2017 (route of administration and anatomical location were not reported). There were no concomitant therapies and adverse effects reported. No product quality complain was involved. On an unspecified date, the RECOMBIVAX HB had two temperature excursion of 34 F (1.11 Celsius Degrees) for 760 hours and 32 F (0 Celsius Degrees) for 168 hours, respectively. The vaccine status was reported as "in excursion". The vaccine storage criteria and type of excursion were reported as "Refrigerator (R)". This is one of several cases from the same reporter. Additional information has been requested.
Left shoulder and arm pain from Tet B.  No erythema, no swelling.  Will follow up in 3-5 days.
Patient vaccinated on 1/28/05 On 2/6/04 developed L thigh cellulitis and high fever with stiff neck.  Patient discharged 2/9/05 and readmitted 2/9/05 with rule out ventricular abscess Information from discharge summary sttes varicella; Medical records sttes rash. msv Information from Discharge summary states varicella. Information from medical record states rash. msv
Patient was given an adult dose of Hepatitis B instead of pediatric dose. Pharmacy was consulted. Patient will need to have 2 more pediatric doses per pharmacist. Dr. contacted the patient's mom to let her know of the incorrect dose patient received.
Just about to pass out/ about passed out all the time; Lightheadedness/dizziness; Stomach's upset; Been sick ever since/has not been feeling good; Arm hurting; Want to asleep, no energy; Food did not taste as it should; Loss of appetite; Headache/ experienced severe headache; This spontaneous case was reported by a patient and describes the occurrence of PRESYNCOPE (Just about to pass out/ about passed out all the time), DIZZINESS (Lightheadedness/dizziness), ABDOMINAL DISCOMFORT (Stomach's upset), MALAISE (Been sick ever since/has not been feeling good) and PAIN IN EXTREMITY (Arm hurting) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 30-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-Mar-2021, the patient experienced PRESYNCOPE (Just about to pass out/ about passed out all the time), DIZZINESS (Lightheadedness/dizziness), ABDOMINAL DISCOMFORT (Stomach's upset), MALAISE (Been sick ever since/has not been feeling good), PAIN IN EXTREMITY (Arm hurting), ASTHENIA (Want to asleep, no energy), AGEUSIA (Food did not taste as it should), DECREASED APPETITE (Loss of appetite) and HEADACHE (Headache/ experienced severe headache). At the time of the report, PRESYNCOPE (Just about to pass out/ about passed out all the time), DIZZINESS (Lightheadedness/dizziness), ABDOMINAL DISCOMFORT (Stomach's upset), MALAISE (Been sick ever since/has not been feeling good), PAIN IN EXTREMITY (Arm hurting), ASTHENIA (Want to asleep, no energy), AGEUSIA (Food did not taste as it should), DECREASED APPETITE (Loss of appetite) and HEADACHE (Headache/ experienced severe headache) had not resolved. Not Provided          No concomitant medications were reported.  No treatment information was provided.   Most recent FOLLOW-UP information incorporated above includes: On 21-Jul-2021: Follow up document received and contains significant information. Outcome of the events Malaise, Pain in extremity, Asthenia, Ageusia  and Decreased appetite from Unknown to Not Recovered / Resolved.Also mentions way of communication to be followed with the patient.
Moderate reaction; Red bad rash at injection site; Red bad rash at injection site; Did not receive her 2nd dose due to side effects; Breakouts at the site of injection; Itchy at the site of injection; Hives at the site of injection; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE REACTION (Breakouts at the site of injection), ADVERSE REACTION (Moderate reaction), VACCINATION SITE ERYTHEMA (Red bad rash at injection site), VACCINATION SITE PRURITUS (Itchy at the site of injection) and VACCINATION SITE URTICARIA (Hives at the site of injection) in an 83-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010DM20) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (No recorded medical history).    On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 31-Jan-2021, the patient experienced VACCINATION SITE REACTION (Breakouts at the site of injection), VACCINATION SITE PRURITUS (Itchy at the site of injection) and VACCINATION SITE URTICARIA (Hives at the site of injection). On an unknown date, the patient experienced ADVERSE REACTION (Moderate reaction), VACCINATION SITE ERYTHEMA (Red bad rash at injection site), VACCINATION SITE RASH (Red bad rash at injection site) and INCOMPLETE COURSE OF VACCINATION (Did not receive her 2nd dose due to side effects). In February 2021, VACCINATION SITE URTICARIA (Hives at the site of injection) had resolved. At the time of the report, VACCINATION SITE REACTION (Breakouts at the site of injection) and VACCINATION SITE PRURITUS (Itchy at the site of injection) had resolved, ADVERSE REACTION (Moderate reaction), VACCINATION SITE ERYTHEMA (Red bad rash at injection site) and INCOMPLETE COURSE OF VACCINATION (Did not receive her 2nd dose due to side effects) outcome was unknown and VACCINATION SITE RASH (Red bad rash at injection site) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant information  provided. No Treatment information  provided   This case was linked to US-MODERNATX, INC.-MOD-2021-070717 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 07-Apr-2021: Dose number, anatomical location were updated. New events moderate reaction, red bad rash at injection site were reported. On 03-May-2021: Second follow up received and appended. Information on second dose updated. Patient states was advised by her physician to not receive her second dose due to her side effects from the first dose.; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-070717:Crosslinked
3 inch by 2 inch oval bruise (red/brown in color) with yellow border located on inner left arm. Warm to touch. Patient reports pain after injection but has since resolved.
Kidney stone; patient is tired all time after receiving Moderna Covid-19 vaccine; This spontaneous case was reported by a patient family member or friend and describes the occurrence of NEPHROLITHIASIS (Kidney stone) in an adult female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. ASKU) for COVID-19 prophylaxis. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced NEPHROLITHIASIS (Kidney stone) (seriousness criterion medically significant) and FATIGUE (patient is tired all time after receiving Moderna Covid-19 vaccine). At the time of the report, NEPHROLITHIASIS (Kidney stone) had not resolved and FATIGUE (patient is tired all time after receiving Moderna Covid-19 vaccine) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication was not reported. It was unknown if the patient had received any other vaccines in the 4 weeks prior to COVID-19 vaccine.  It was reported that the patient received Moderna Covid-19 vaccines and had a kidney stone. Also, the patient was tired all the time since receiving the Moderna Covid-19 vaccines. The patient received the most recent Spikevax dose on an unspecified date. It was reported that the patient might have received another Covid-19 booster dose at her local Pharmacy two weeks ago after Spikevax dose.  Treatment medication was not reported.  Company comment: This is a spontaneous case concerning a female patient of unknown age with no reported medical history, who experienced the serious (due to medically significant) unexpected, event of Nephrolithiasis and a non-serious expected event of fatigue. The event Nephrolithiasis occurred on an unknown date after a dose of mRNA-1273 (date of vaccination, dose number and onset date were not provided, hence, latency could not be estimated). Clinical course, diagnostic procedures and treatment were not provided.  The outcome of the event Nephrolithiasis was reported as not recovered. The event Nephrolithiasis is considered as not related to the vaccine due to lack of biological plausibility. The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report.   This case was linked to US-MODERNATX, INC.-MOD-2023-747372 (E2B Linked Report).   Reporter did not allow further contact; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-747372:Same patient (different vaccine)
Patient states the next morning after getting the vaccine, she woke up and felt chills and body aches. And then when she tried to get up she fainted.
After 3 months still running fever and feels like  my muscles r being pulled off in my legs
Mild cellulitis left arm 2 hours after immunization. Macular erythematous rash left upper deltoid.
On the day of the vaccine, I had dizziness, weird dreams and sore arm. Seven days later I began with itchiness at the vaccination site and it became a round red rash with increased itchiness for 2-3 more days.
I started having tachycardia (rate in 180s) at about 3am on 1/29/2021. This lasted for about 36 hours. It also felt like my heart rate would drop drastically. I have a pacemaker, so I downloaded my report and I could see that my pacing had doubled from my normal activity. I have had my pacemaker for 4 years and have always been at 1% use for my pacemaker. After the vaccine, my rate went up to 2% (I was requiring my pacemaker double from what I normally would). I downloaded my report again about a month later and it was still at 2% usage. I go for my 6 month pacemaker check in June and will see what the usage is at that time. My pacemaker is used when my heart goes into 3rd degree AV block. So according to my pacemaker report, I was going into 3rd degree heart block twice as much as I usually do, in addition to my heart rate racing in the 180-190s. My heart rate would be racing and then drastically drop so low my pacemaker would kick in.
Patient approached the pharmacy counter from the observation area and reported lightheaded, drowsiness and confused. As I was approaching patient, patient was about to fall to the ground. I grabbed the patient and seated him on the chair nearby and noticed he was incoherent. I started talking to him. He felt very warm. I asked my staff to bring the Epinephrine and blood pressure cuff. I started taking his bp. I asked my staff to call 911. Initially it was 91/79 pulse 58, then 10 minutes later it was 103/68 pulse 66. There was no airway obstruction, or shortness of breath, or chest pain reported. No hives, itching reported. The EMS arrived around 5:55pm and started assessing patient. I helped patient call his emergency contact person and spoke to him.
Redness, swelling at site (L) arm. 5 x 6 cm warm to touch.
I'm not sure where to report this:  When I received my first COVID vaccine yesterday, the lady pulled out the syringe immediately upon contact with my arm (probably too quick for the vaccine to disburse in my arm) and blood and vaccine spat out all over the inside of my car door.  I'm not taking any blood thinners.  The problem that I need to have an answer to is did I get enough vaccine to make it fully effective?  Please contact me to let me know.  How do I find out if I received a full dosage?  Is there a way to test it?
2:25 pm onset of dizziness.  Shaking to arms/hands, arms itching, lower lips tingling, blurred vision off/on with off/on approximately 2:55 pm.  3:14 pm vomits small amt whitish tan emesis.  Denied any other sx other than dizziness.  2:55 pm BP 149/79, Pulse 73.  3:05 pm BP 127/57, 55, 3:14 pm BP 121/77, P 75.  3:28 pm 127/75, P 71, sitting 113/51, P 64, standing 127/75, P 87.
lips had swollen; throat is sore; arm pain; extremely tired; This is a spontaneous report from a contactable healthcare professional, the patient. A 29-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 21May2021 at 16:30 (at the age of 29-year-old) as a single dose for COVID-19 immunisation. Medical history included asthma and allergy to hazelnut and cashews. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any medication within two weeks of vaccination. On 21May2021 at 17:00, the patient experienced lips had swollen. Her throat was sore from it, had arm pain and was extremely tired after words. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. On an unknown date, the patient underwent rapid COVID-19 nasal swab test, post vaccination and the result was negative. Since the vaccination, the patient had been tested for COVID-19. The clinical outcomes of the events swollen lips, sore throat, arm pain and extremely tired was recovering at the time of this report.    No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Pt received tetanus shot subsequent to a dog bite, also received antibiotics for cellulitis. Pt went home and experienced loss of arm/leg control, fell and was subsequently admitted. Admitting MD could not rule out vaccine effect but felt weakness is probably due to infection. Pt claimed recalling feeling weird with previous shot of tetanus 10 yrs before. 04/10/07-records received from facility for DOS: 08/08/06-cellulitis status post dog bite on dorsum left hand with erythema and mild swelling. C/O generalized weakness, fell at home no loss of consciousness. Temp at home 102.9 TX with IVAB. Received tetanus shot day of dog bite.
my face was paralyzed slightly due to Bell's palsy; my tongue had a sore; I got pain in my jaw and pain in my left side of my neck for about 3days; I got pain in my jaw and pain in my left side of my neck for about 3days; This is a spontaneous report from a contactable consumer (patient). A 33-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE lot number: EP7534) via an unspecified route of administration, administered on the left arm on 17Mar2021 13:00 at a single dose for COVID-19 immunisation. Medical history included Bell's palsy (prior case, 9 1/2 years ago). The patient's concomitant medications were not reported. On 21Mar2021 12:00 PM, within the 3rd day her tongue had a sore. It went away and she got pain in her jaw and pain in the left side of her neck for about 3days. Then, her face was paralyzed slightly due to Bell's palsy. It went away within a week and a half. Treatment was received for the events which included medication to help with Bell's palsy. The events resulted in doctor or other healthcare professional office/clinic visit. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. There were no other medications the patient received within 2 weeks of vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. Post vaccination, the patient has not been tested for COVID-19. Patient was not pregnant. The facility where the vaccine was administered was in a Public Health Department. No known allergies. Outcome of the events was recovered on an unspecified date in 2021.
Patient presented to the hospital with autoimmune hemolytic anemia after reportedly receiving Pfizer COVID19 vaccine 3 weeks prior. For some reason her vaccination is not documented on the computer.
pt recvd vax;on 4dec94 devel fussiness & feverishness,6dec PO thrush & eruption(morbilliform),bronchitis;v,d,weight dec;9dec resolving viral exhanthem,thrush;dehydr,IDDM w/acidocis CO2 dec,Na dec to 135; tx IV's;
1 day after injections in the evening arm felt bruised then started to itch and swell around injection sites into a red oval.
nausea after the second dose; This spontaneous case was reported by a consumer and describes the occurrence of NAUSEA (nausea after the second dose) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 044A21A and 029A21A) for COVID-19 vaccination.     Concurrent medical conditions included Nausea (suffering with nausea for two years), Vomiting (suffering with vomiting for two years) and Itching. Concomitant products included ATORVASTATIN for Cholesterol blood excessive, HYDROXYZINE for Itching, ONDANSETRON for Nausea and Vomiting, AZITHROMYCIN (AZO) for Supplementation therapy, COGNIUM for an unknown indication.   On 27-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 04-Apr-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced NAUSEA (nausea after the second dose). The patient was treated with ONDANSETRON for Nausea, at a dose of 4 mg. At the time of the report, NAUSEA (nausea after the second dose) outcome was unknown. Not Provided          Concomitant products included Azo as a urinary health supplement.  Action taken with mRNA-1273 in response to event was not applicable.   Most recent FOLLOW-UP information incorporated above includes: On 26-Jun-2021: Follow up received on 26 June 2021 contains no new information.
Booster received on 12/28/2021 and on 12/31/2021 I started to have a chronic, gushing nosebleed that continued intermittently every few hours for the next seven days.  The nosebleed was very high up, not coming from the front end of my nose.  It would often start gushing down my throat before it even started coming out the front of my nose.  It was very hard to get it to stop bleeding every time.
Rash, vomiting nausea on 2/22/2021  Diarrhea on 2/23/2021 Migraine and diarrhea on 2/24/2021
14Jul90 mother reported in the evening /p vaccine, child had fever 105 F & lethargic. Fever lasted 3 days but at 102 F.